BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 29752871)

  • 1. Small molecule targeting of the actin associating protein tropomyosin Tpm3.1 increases neuroblastoma cell response to inhibition of Rac-mediated multicellular invasion.
    Mitchell CB; Stehn JR; O'Neill GM
    Cytoskeleton (Hoboken); 2018 Jul; 75(7):307-317. PubMed ID: 29752871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac GTPase regulation of 3D invasion in neuroblastomas lacking MYCN amplification.
    Mitchell CB; O'Neill GM
    Cell Adh Migr; 2017 Jan; 11(1):68-79. PubMed ID: 27224546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular integration of the anti-tropomyosin compound ATM-3507 into the coiled coil overlap region of the cancer-associated Tpm3.1.
    Janco M; Rynkiewicz MJ; Li L; Hook J; Eiffe E; Ghosh A; Böcking T; Lehman WJ; Hardeman EC; Gunning PW
    Sci Rep; 2019 Aug; 9(1):11262. PubMed ID: 31375704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Cancer-Targeted Tropomyosin Inhibitors and Their Synergy with Microtubule Drugs.
    Currier MA; Stehn JR; Swain A; Chen D; Hook J; Eiffe E; Heaton A; Brown D; Nartker BA; Eaves DW; Kloss N; Treutlein H; Zeng J; Alieva IB; Dugina VB; Hardeman EC; Gunning PW; Cripe TP
    Mol Cancer Ther; 2017 Aug; 16(8):1555-1565. PubMed ID: 28522589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-muscle tropomyosin (Tpm3) is crucial for asymmetric cell division and maintenance of cortical integrity in mouse oocytes.
    Jang WI; Jo YJ; Kim HC; Jia JL; Namgoong S; Kim NH
    Cell Cycle; 2014; 13(15):2359-69. PubMed ID: 25483187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropomyosin regulates cell migration during skin wound healing.
    Lees JG; Ching YW; Adams DH; Bach CT; Samuel MS; Kee AJ; Hardeman EC; Gunning P; Cowin AJ; O'Neill GM
    J Invest Dermatol; 2013 May; 133(5):1330-9. PubMed ID: 23303457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia alters the recruitment of tropomyosins into the actin stress fibres of neuroblastoma cells.
    Glass JJ; Phillips PA; Gunning PW; Stehn JR
    BMC Cancer; 2015 Oct; 15():712. PubMed ID: 26475688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small molecule inhibitor of tropomyosin dissociates actin binding from tropomyosin-directed regulation of actin dynamics.
    Bonello TT; Janco M; Hook J; Byun A; Appaduray M; Dedova I; Hitchcock-DeGregori S; Hardeman EC; Stehn JR; Böcking T; Gunning PW
    Sci Rep; 2016 Jan; 6():19816. PubMed ID: 26804624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment Kinetics of Tropomyosin Tpm3.1 to Actin Filament Bundles in the Cytoskeleton Is Independent of Actin Filament Kinetics.
    Appaduray MA; Masedunskas A; Bryce NS; Lucas CA; Warren SC; Timpson P; Stear JH; Gunning PW; Hardeman EC
    PLoS One; 2016; 11(12):e0168203. PubMed ID: 27977753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the Actin-Associated Tropomyosin
    Tomanić T; Martin C; Stefen H; Parić E; Gunning P; Fath T
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma.
    Felgenhauer J; Tomino L; Selich-Anderson J; Bopp E; Shah N
    Neoplasia; 2018 Oct; 20(10):965-974. PubMed ID: 30153557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
    Croucher JL; Iyer R; Li N; Molteni V; Loren J; Gordon WP; Tuntland T; Liu B; Brodeur GM
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):131-41. PubMed ID: 25394774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of actin filament turnover by cofilin-1 and cytoplasmic tropomyosin isoforms.
    Ostrowska Z; Robaszkiewicz K; Moraczewska J
    Biochim Biophys Acta Proteins Proteom; 2017 Jan; 1865(1):88-98. PubMed ID: 27693909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells.
    Maddala R; Reddy VN; Epstein DL; Rao V
    Mol Vis; 2003 Jul; 9():329-36. PubMed ID: 12876554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth.
    Lamers F; Schild L; den Hartog IJ; Ebus ME; Westerhout EM; Ora I; Koster J; Versteeg R; Caron HN; Molenaar JJ
    Eur J Cancer; 2012 Nov; 48(16):3093-103. PubMed ID: 22366560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the actin-binding protein, tropomyosin 1, in neuroblastoma.
    Yager ML; Hughes JA; Lovicu FJ; Gunning PW; Weinberger RP; O'Neill GM
    Br J Cancer; 2003 Sep; 89(5):860-3. PubMed ID: 12942118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.
    Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T
    Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
    Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
    Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2.
    Marcoux N; Vuori K
    Oncogene; 2003 Sep; 22(38):6100-6. PubMed ID: 12955089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents.
    Xu X; Wang Y; Bryce NS; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW
    Br J Cancer; 2021 Jul; 125(2):265-276. PubMed ID: 33981016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.